دورية أكاديمية
Radioiodine therapy during the COVID-19 pandemic in a public reference hospital in Brazil: an experience report.
| العنوان: | Radioiodine therapy during the COVID-19 pandemic in a public reference hospital in Brazil: an experience report. |
|---|---|
| المؤلفون: | Fontes LF; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil.; College of Pharmacy, Center for Pharmaceutical Care Studies, Federal University of Minas Gerais, Belo Horizonte, MG 31270-901, Brazil., Pujatti PB; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil., da Silva JWE; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil., Costa CH; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil., Palhota C; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil., de Oliveira AP; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil., de Mello RCR; Nuclear Medicine Service, Cancer Hospital I, National Cancer Institute (INCA), Rio de Janeiro, RJ 20230-130, Brazil. |
| المصدر: | Radiation protection dosimetry [Radiat Prot Dosimetry] 2023 Jul 05; Vol. 199 (11), pp. 1195-1201. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8109958 Publication Model: Print Cited Medium: Internet ISSN: 1742-3406 (Electronic) Linking ISSN: 01448420 NLM ISO Abbreviation: Radiat Prot Dosimetry Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2004- : Oxford, UK : Oxford University Press Original Publication: Ashford, Kent : Nuclear Technology Pub., c1981- |
| مواضيع طبية MeSH: | COVID-19*/radiotherapy, Humans ; Iodine Radioisotopes/therapeutic use ; Brazil/epidemiology ; Pandemics ; Hospitals |
| مستخلص: | COVID-2019 has resulted in an emerging respiratory infection that has spread as a pandemic since January 2020. Nuclear Medicine Services and its workers experienced a dramatic change in their clinical routine. They were required to adjust protocols for this new health condition. Regarding radioiodine therapy (RIT), initial orientations were to postpone treatments. In Brazil, National Nuclear Energy Commission prepared guidelines. It authorized RIT to employ activities over 1850 MBq in an outpatient setting on an exceptional basis. This study reports the RIT experience of a Brazilian hospital during the COVID-19 pandemic, intending to evaluate the applicability of outpatient treatment employing over 1850 MBq of I-131 on a large scale. During referred period, 106 patients at our service had an indication for RIT, of which 58 agreed to participate in the research and provided informed consent. Majority of patients did not meet the minimum requirements for outpatient treatment using doses > 1850 MBq. (© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.) |
| المشرفين على المادة: | 0 (Iodine-131) 0 (Iodine Radioisotopes) |
| تواريخ الأحداث: | Date Created: 20230529 Date Completed: 20230707 Latest Revision: 20230718 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1093/rpd/ncad163 |
| PMID: | 37247636 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1742-3406 |
|---|---|
| DOI: | 10.1093/rpd/ncad163 |